KELSEY MOLLURA: Open Payments
NPI 1942530522 · ALIQUIPPA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 60 payments from 16 companies in 2025. Trend: 2023 $768 · 2024 $786 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $391 |
| Novo Nordisk Inc | 7 | $189 |
| Abbott Laboratories | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $51 |
| Astellas Pharma US Inc | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Amgen Inc. | 2 | $36 |
Products named: QULIPTA, Wegovy, Ozempic, PROCLAIM, Auvelity, VRAYLAR, UBRELVY, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
